<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Molecular Microbiology (2009) 74(3), 529&#226;&#8364;&#8220;540 &#228;&#352;?                                               doi:10.1111/j.1365-2958.2009.06761.x <br />                                                                                               First published online 24 June 2009 <br />  <br />  <br />  <br /> Dissecting essentiality bifunctional trypanothione <br /> synthetase-amidase Trypanosoma brucei using chemical <br /> and genetic methods                          mmi_6761 529..540 <br />  <br />  <br />  <br />  <br /> Susan Wyllie, Sandra L. Oza, Stephen Patterson,                    Introduction <br /> Daniel Spinks, Stephen Thompson and <br /> Alan H. Fairlamb*                                                  The protozoan parasite Trypanosoma brucei caus- <br /> Division Biological Chemistry Drug Discovery,               ative agent human African trypanosomiasis (HAT), <br /> Wellcome Trust Biocentre, College Life Sciences,                commonly known sleeping sickness. This disease, <br /> University Dundee, Dundee, DD1 5EH, Scotland, UK.               thought largely controlled 1960s, has <br />                                                                    re-emerged major threat human health a <br />                                                                    number factors including lack financial resources, <br /> Summary                                                            conflict affected countries failure adequately <br />                                                                    monitor infection. Currently, World Health Organisa- <br /> The bifunctional trypanothione synthetase-amidase <br />                                                                    tion reports 400 000 people infected with <br /> (TRYS) comprises structurally distinct catalytic <br />                                                                    HAT, resulting annual death toll than <br /> domains synthesis hydrolysis trypan- <br />                                                                    50 000 (Stuart et al., 2008). In absence effec- <br /> othione (N 1,N 8-bis(glutathionyl)spermidine). This <br />                                                                    tive vaccine, treatment solely dependent piti- <br /> unique dithiol plays pivotal role thiol-redox <br />                                                                    fully small repertoire drugs suffer a <br /> homeostasis defence chemical and <br />                                                                    number problems including severe toxic side-effects <br /> oxidative stress trypanosomatids. A tetracycline- <br />                                                                    (Fairlamb, 2003) acquired drug resistance (Barrett <br /> dependent conditional double <span id='am-317' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-318' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-319' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-320' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-321' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-322' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-323' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-324' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-325' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-326' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-327' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-328' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-329' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-330' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-331' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-332' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-333' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-334' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-335' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-336' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-337' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-338' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-339' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-340' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-341' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-342' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-343' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-344' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-345' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-346' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-347' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-348' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-349' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-350' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-351' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-352' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-353' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-354' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-355' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-356' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-357' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-358' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-359' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-360' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-361' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-362' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-363' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-364' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-365' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-366' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-367' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-368' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-369' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-370' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-371' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-372' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-373' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-374' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-375' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-376' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-377' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-378' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-379' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-380' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-381' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-382' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-383' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-384' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-385' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-386' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-387' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-388' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-389' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-390' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-391' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-392' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-393' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-394' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span>knockout</span> TRYS <br />                                                                    Fairlamb, 1999). <span id='am-4' about='protege:TO' typeof='owl:Thing'>To</span> compound difficulties, <br /> (cDKO) generated bloodstream Trypanosoma <br />                                                                    current chemotherapeutic treatments also <br /> brucei. Culture cDKO parasites tetracycline <br />                                                                    require lengthy periods hospitalization pro- <br /> induction resulted loss trypanothione accu- <br />                                                                    hibitively expensive (Stuart et al., 2008). With new <br /> mulation glutathione, followed growth inhibition <br />                                                                    drugs treatment HAT pipeline, con- <br /> and cell lysis 6 days. In absence inducer, <br />                                                                    certed effort identify, characterize and <br /> cDKO cells unable infect mice, confirming that <br />                                                                    validate novel molecular targets urgently required for <br /> this enzyme essential virulence vivo as <br />                                                                    drug discovery. <br /> in vitro. To establish enzymatic functions <br />                                                                       In search anti-parasitic drug targets, metabolic <br /> were essential, amidase-dead mutant cDKO line <br />                                                                    pathways essential parasite <span id='am-5' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-6' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-7' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-8' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-12' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-17' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-21' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-23' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-28' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-30' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-40' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-52' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-57' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-62' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-65' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-68' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-70' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-73' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-76' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-78' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-80' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-82' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span>survival</span> <br /> was generated. In presence inducer, line <br />                                                                    absent host logical starting points (El <br /> showed decreased growth vitro decreased viru- <br />                                                                    Sayed et al., 2005). One pathway thiol <br /> lence vivo, indicating amidase function is <br />                                                                    metabolism trypanosomes Leishmania. These <br /> not absolutely required viability. The druggability <br />                                                                    parasites uniquely dependent trypanothione <br /> of TRYS assessed using potent small molecule <br />                                                                    (N 1,N 8-bis(glutathionyl)spermidine, T[SH]2) prin- <br /> inhibitor developed laboratory. Growth inhibi- <br />                                                                    cipal thiol, contrast organisms (including <br /> tion correlated rank order cDKO, single KO, wild- <br />                                                                    mammalian hosts) utilize glutathione (g-L- <br /> type overexpressing lines produced the <br />                                                                    glutamyl-L-cysteinylglycine, GSH) (Fairlamb et al., 1985). <br /> predicted biochemical <span id='am-161' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-162' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-163' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-169' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-173' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-174' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-176' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-177' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-179' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-180' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-183' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-186' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-192' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-193' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-195' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-196' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-199' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-200' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-205' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-207' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-210' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-221' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-223' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-225' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-226' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-228' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-234' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-237' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-238' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span>phenotype</span>. The synthetase <br />                                                                    This dithiol primarily responsible maintenance <br /> function TRYS unequivocally validated a <br />                                                                    thiol-redox homeostasis trypanosomatids, and <br /> drug target chemical genetic methods. <br />                                                                    involved number critical cellular processes <br />                                                                    including deoxyribonucleotide synthesis (Dormeyer <br /> Accepted 3 June, 2009. *For correspondence. E-mail a.h.fairlamb@   et al., 2001), defence oxidative stress (Ariy- <br /> dundee.ac.uk; Tel. (+44) 1382 38 5155; Fax (+44) 1382 38 5542.     anayagam Fairlamb, 2001) xenobiotics (Vickers <br /> Re-use article permitted accordance Terms <br /> and Conditions set http://www3.interscience.wiley.com/      et al., 2004). Trypanothione implicated <br /> authorresources/onlineopen.html                                    mode action mechanism of <br /> &#194;&#169; 2009 The Authors <br /> Journal compilation &#194;&#169; 2009 Blackwell Publishing Ltd <br />  530 S. Wyllie et al. &#228;&#352;? <br />  <br /> resistance antimonial drugs Leishmania spp.                 Results discussion <br /> (Mukhopadhyay et al., 1996; Wyllie et al., 2004; Croft <br /> et al., 2006) defence chemical                 Generation TRYS conditional <span id='am-83' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-84' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-86' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-98' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-103' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-109' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-114' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-120' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-121' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-123' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-137' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-139' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-141' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-142' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-144' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-145' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-146' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-147' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-151' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-154' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-155' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-156' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-159' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-160' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span>null mutants</span> <br /> oxidant stress induced arsenicals nifurtimox            To date, essentiality T. brucei trypanothione syn- <br /> T. brucei (Fairlamb et al., 1989; Ariyanayagam et al.,            thetase (TRYS) demonstrated RNAi <br /> 2005; Alibu et al., 2006). Therefore, attempt            (Comini et al., 2004; Ariyanayagam et al., 2005), meth- <br /> exploit essential unique metabolite, T[SH]2-             odology lacks robustness classical gene <br /> dependent biosynthetic enzymes                  replacement. With mind, sought definitively <br /> major focus drug discovery.                                   classify enzyme drug target bloodstream try- <br />    The pivotal role T[SH]2 metabolism viability     panosomes replacing TRYS drug-resistance <br /> virulence trypanosomatids unequivocally               genes (Fig. 1A). Previous studies demonstrated that <br /> demonstrated using genetic techniques classical           TRYS present single-copy gene haploid <br /> <span id='am-395' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-396' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-397' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-398' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-399' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-400' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-401' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-402' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-403' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-404' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-405' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-406' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-407' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-408' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-409' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-410' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-411' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-412' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-413' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-414' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-415' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-416' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-417' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-418' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-419' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-420' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-421' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-422' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-423' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-424' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-425' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-426' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-427' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-428' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-429' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-430' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-431' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-432' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-433' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-434' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-435' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-436' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-437' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-438' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-439' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-440' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-441' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-442' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-443' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-444' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-445' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-446' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-447' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-448' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-449' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-450' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-451' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-452' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-453' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-454' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-455' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-456' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-457' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-458' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-459' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-460' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-461' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-462' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-463' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-464' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-465' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-466' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-467' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-468' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-469' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-470' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-471' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-472' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span>gene knockout</span> <span id='am-473' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-474' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-475' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-476' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-477' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-478' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-479' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-480' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-481' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-482' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-483' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-484' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-485' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-486' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-487' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-488' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-489' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-490' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-491' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-492' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-493' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-494' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-495' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-496' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-497' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-498' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-499' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-500' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-501' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-502' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-503' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-504' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-505' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-506' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-507' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-508' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-509' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-510' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-511' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-512' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-513' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-514' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-515' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-516' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-517' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-518' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-519' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-520' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-521' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-522' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-523' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-524' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-525' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-526' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-527' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-528' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-529' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-530' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-531' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-532' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-533' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-534' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-535' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-536' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-537' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-538' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-539' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-540' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-541' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-542' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-543' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-544' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-545' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-546' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-547' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-548' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-549' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-550' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span>RNA interference</span> (RNAi).                        genome T. brucei (Oza et al., 2003). The TRYS <br /> Trypanothione-dependent enzymes vali-              gene copy replaced puromycin N-acetyl <br /> dated potential drug targets using methodologies         transferase (PAC) gene homologous recombination <br /> include: trypanothione reductase (Tovar et al., 1998;             subsequent selection puromycin resistance, gen- <br /> Krieger et al., 2000), tryparedoxin (Wilkinson et al., 2003)      erating single knockout (SKO) cell line. Attempts to <br /> and tryparedoxin peroxidase (Wilkinson et al., 2003).             create null mutant directly replacing second <br /> Unsurprisingly, enzyme responsible biosynthe-         allelic copy hygromycin-resistance gene (hygro- <br /> sis T[SH]2, bifunctional trypanothione synthetase-         mycin phosphotransferase, HYG) proved unsuccessful, <br /> amidase (TRYS), confirmed essential              suggesting TRYS essential viability <br /> for viability proliferation T. brucei bloodstream      T. brucei bloodstream parasites. Consequently, con- <br /> (Comini et al., 2004) procyclic forms (Ariyanayagam           ditional double knockout (cDKO) cell line generated <br /> et al., 2005) RNAi. In pathogenic trypanosomatids,             introducing ectopic tetracycline-inducible copy <br /> TRYS catalyses synthesis T[SH]2 GSH               TRYS prior replacing second copy HYG. <br /> spermidine two-step, ATP-dependent reaction            This ectopic copy TRYS inserted rDNA <br /> glutathionylspermidine intermediate. In addition          locus SKO cell line using pLew 100 vector encod- <br /> role biosynthesis, N-terminal domain TRYS          ing blasticidin-resistance gene (BSD) followed dele- <br /> functions amidase, hydrolysing T[SH]2 GSH            tion second genomic copy HYG. As the <br /> spermidine, glutathionylspermidine. The bio-            modified T. brucei 427 cell line [wild-type (WT)] used in <br /> logical significance TRYS-amidase, classified             study constitutively expresses T7 RNA poly- <br /> cysteine&#226;&#8364;&#8220;histidine-dependent aminohydrolase/peptidase             merase tetracycline repressor protein, result- <br /> amidase (Bateman Rawlings, 2003; Rigden et al.,               ing cell line TRYS conditional null mutant where <br /> 2003), fully understood. However, sug-         TRYS expression depends presence tetracy- <br /> gested conflicting biosynthetic hydrolytic           cline (cDKO). Southern blot analysis genomic DNA <br /> functions enzyme enable parasite               cell lines generated stage process <br /> respond fluctuating cellular requirements             confirmed validity TRYS conditional null mutant <br /> T[SH]2 polyamines, essential proliferation dif-       (Fig. 1B). <br /> ferentiation (Fairlamb Cerami, 1992; Bacchi and <br /> Yarlett, 1995). <br />                                                                   TRYS essential bloodstream T. brucei vitro <br />    In current study, assessed essentiality of <br /> TRYS classical gene replacement fulfil stringent        In HMI9-T culture medium, significant difference could <br /> target validation criteria University Dundee Drug       detected growth rates WT SKO <br /> Discovery <span id='am-1' about='Thesaurus:Unit' typeof='owl:Thing'>Unit</span> (Frearson et al., 2007). Gene replacement          cells, generation times 9.6 &#226;&#171;&#190; 0.1 9.5 &#226;&#171;&#190; 0.2 h <br /> is preferred method genetic validation             respectively (data shown). Indeed, cDKO cell line, <br /> &#226;&#8364;&#732;off-target&#226;&#8364;&#8482; effects ruled using RNAi. More-        grown presence tetracycline, showed marked <br /> over, target knock-down RNAi does permit inde-             growth phenotype doubling time 9.9 &#226;&#171;&#190; 0.02 h <br /> pendent analysis bifunctional enzymes                  (Fig. 2A). Following removal tetracycline the <br /> DHFR-TS (Sienkiewicz et al., 2008) TRYS. Using               medium, cDKO cells continued grow exponentially for <br /> combination classical gene replacement, mutagenesis            3 days. Growth slowed day 4 culture cells <br /> and chemical intervention methods, dissect oppos-          finally dying day 8. To determine actual point where <br /> ing synthetic hydrolytic functions TRYS order        cDKO parasites grown absence tetracycline com- <br /> independently study respective roles T. brucei cell      pletely lose viability, cells subcultured day into <br /> virulence viability.                                          medium containing tetracycline. Up 6th day of <br />  <br />                                                                                                               &#194;&#169; 2009 The Authors <br />                                          Journal compilation &#194;&#169; 2009 Blackwell Publishing Ltd, Molecular Microbiology, 74, 529&#226;&#8364;&#8220;540 <br />                                                                                                    Synthetase amidase activity TRYS essential 531 <br />  <br />  A                               1st allele                                    cytostatic highly advantageous drug discovery <br />                       5&#226;&#8364;&#178;                              3&#226;&#8364;&#178; <br />   i <br />                                   TRYS                                         perspective drug therapy dependent a <br />                                                                                fully functional immune response (Frearson et al., 2007). <br />                                          PAC <br />  <br />                                                                                Biochemical analyses TRYS cDKO cells <br />                                        500 bp <br />                                                                                The &#226;&#8364;&#732;slow death&#226;&#8364;&#8482; phenotype cDKO cells following the <br />                                     rDNA                                       removal tetracycline partly explained low <br />                               PARP <br />                                                                                turnover TRYS product, T[SH]2. Western blot <br />  ii                           Promoter                                         analysis cell extracts revealed the <br />                      T7       TetR                                             levels enzyme declined following removal of <br />                      Promoter Operator <br />              rDNA   BSD                        TRYS             rDNA           tetracycline, day 6 TRYS no <br />                                                                                longer detectable (Fig. 2B). This observation suggests <br />                                                                                rate turnover TRYS (or T[SH]2) low in <br />                                  2st allele <br />                                   TRYS                                         T. brucei TRYS (or T[SH]2) removed <span id='am-3' about='protege:FROM' typeof='owl:Thing'>from</span> <br />  iii                                                                           cell dilution cell division absence of <br />                                        HYG                                     protein synthesis. Nevertheless, death of <br />                                                                                cDKO cells coinciding disappearance TRYS <br />                                                                                confirms enzyme essential in <br />  B             1          2        3           4                               bloodstream trypanosomes. <br />                                                                                   The effect TRYS depletion intracellular thiols was <br />        kb                                                                      studied high-performance liquid chromatography <br />        12 <br />                                                            ectopic TbTRYS      (HPLC). Due number cells required analy- <br />         7 <br />         5 <br />         4                                                                      sis, thiols monitored cultures 4 days <br />         3                                                  endogenous TbTRYS <br />                                                                                following removal tetracycline. The cessation of <br />          2 <br />        1.6                                                                     ectopic TRYS expression parasites a <br />                                                                                pronounced effect intracellular thiol levels (Fig. 2C). <br />                                                                                Glutathione, substrate TRYS, accumulated cDKO <br /> Fig. 1. Genotypic analysis WT, SKO cDKO cell lines.                     cells absence tetracycline, 4 days, <br /> A. Schematic representation stepwise generation the <br /> TRYS cDKO cell line T. brucei. (i) One allele TRYS                   levels reach 160% seen control cells <br /> replaced puromycin-resistance gene (PAC) homologous                (cDKO cells plus tetracycline). In contrast, T[SH]2 and <br /> recombination, generating DTRYS::PAC cell line (SKO); (ii)                   glutathionylspermidine, products enzyme reac- <br /> tetracycline-inducible ectopic copy TRYS introduced the <br /> rDNA, generating TRYS TiDTRYS::PAC cell line; (iii)                      tion, fell considerably. Indeed, T[SH]2 levels these <br /> tetracycline induces expression ectopic copy,                   parasites fell 16.5% control levels. As 4 day cultures <br /> remaining allele replaced hygromycin resistance gene                showed minimally retarded growth comparison <br /> (HYG) homologous recombination, resulting conditional <br /> double knockout cell line TRYS TiDTRYS::PAC/DTRYS::HYG                         control cells, appear bloodstream trypa- <br /> (cDKO).                                                                        nosomes, vitro, survive vanishingly <br /> B. Confirmation genotype T. brucei TRYS conditional double               small amounts T[SH]2. However, noted that <br /> knockout cell line. Southern blot analysis PstI-digested genomic <br /> DNA (~5 mg) wild-type T. brucei cells (lane 1), DTRYS::PAC                HMI9-T culture medium used studies rich in <br /> (lane 2), TRYS TiDTRYS::PAC (lane 3)                                       reducing agents thioglycerol (56 mM) cys- <br /> TRYS TiDTRYS::PAC/DTRYS::HYG (lane 4) cells; TRYS ORF                      teine (1.5 mM) protect thiol-depleted <br /> probe shows allelic TbTRYS 3 kb ectopic copy <br /> TbTRYS Ti ~10 kb.                                                           cells oxidant stress. <br />  <br />  <br />                                                                                Virulence cDKO parasites mice <br /> culture cells remained viable absence tetracy- <br /> cline; however, point viable cDKO cells                         The oxidative environment vivo significantly different <br /> could recovered culture 10 days.                           vitro culture conditions, underlining importance <br /> Failure cell line grow absence                        carrying drug target validation studies appropri- <br /> tetracycline-induced expression TRYS confirms                          ate animal models (Frearson et al., 2007). With in <br /> this enzyme essential bloodstream T. brucei viability.                  mind, groups mice inoculated WT, cDKO or <br /> Interestingly, ectopic expression L. major TRYS                         cDKO parasites grown absence of <br /> was equally capable complementing loss                           tetracycline 24 h. Mice infected tetracycline- <br /> endogenous TRYS cDKO cell line (Fig. S1). The                           treated parasites dosed doxycycline their <br /> fact loss TRYS activity trypanocidal                    drinking water 5 days prior to, infection to <br />  <br /> &#194;&#169; 2009 The Authors <br /> Journal compilation &#194;&#169; 2009 Blackwell Publishing Ltd, Molecular Microbiology, 74, 529&#226;&#8364;&#8220;540 <br />  532 S. Wyllie et al. &#228;&#352;? <br />  <br /> A                               1e11                                                          B <br />                                 1e10 <br /> Cumulative cell numbers, ml-1 <br />  <br />  <br />                                  1e9 <br />  <br />                                  1e8 <br />                                                                                               TRYS <br />                                  1e7 <br />  <br />                                  1e6 <br />                                                                                               PTR1 <br />                                  1e5                                                                    WT        cDKO        SKO       cDKO         cDKO cDKO <br />                                 10000                                                                             + TET                 -TET         -TET -TET <br />                                                                                                                                         Day 2        Day 4 Day 6 <br />                                 1000 <br />  <br />                                  100 <br />  <br />                                         0   2     4          6   8 <br />                                                 Time, days <br />  <br />                                                                  C                      180 <br />  <br />                                                                                         160 <br />  <br />                                                                                         140 <br />                                                                  Thiols, % control <br />  <br />  <br />  <br />  <br />                                                                                         120 <br />  <br />                                                                                         100 <br />  <br />                                                                                         80 <br />  <br />                                                                                         60 <br />  <br />                                                                                         40 <br />  <br />                                                                                         20 <br />  <br />                                                                                          0 <br />  <br />                                                                                               0          2                4 <br />                                                                                                      Time, days <br />  <br /> Fig. 2. Growth characteristics biochemical analysis cDKO cells vitro. <br /> A. The growth cDKO cell line HMI9-T media monitored presence (closed circles) absence tetracycline (open circles, <br /> dashed line). The arrow indicates point viable cells longer recoverable subcultured 10 days medium <br /> containing tetracycline. <br /> B. Immunoblots cell extracts WT, SKO cDKO (plus minus tetracycline) cells probed antiserum T. brucei TRYS and <br /> to T. brucei PTR1 control (1 &#194;&#165; 107 parasites lane). <br /> C. Intracellular T[SH]2 (closed circles) GSH (open circles) levels cDKO cells following removal tetracycline cultures. Initial <br /> levels T[SH]2 GSH untreated cells 0.42 0.54 nmol(108 cells)-1 respectively. Each data point represents the <br /> means &#226;&#171;&#190; standard deviations triplicate determinations. <br />  <br />  <br /> maintain expression ectopic TRYS. Infections                                                     mutants essential genes T. brucei (Chang et al., <br /> monitored 30 day period survival curves                                                    2002; Roper et al., 2002). Collectively, results <br /> each infection shown Fig. 3. Mice infected WT                                                confirm TRYS essential parasite survival a <br /> parasites succumbed infection day 5                                                   mammalian host. <br /> also case mice infected cells expressing <br /> ectopic TRYS (cDKO plus doxycycline). In contrast, four <br />                                                                                                          Chemical validation TRYS drug target in <br /> out mice infected cDKO cells absence of <br />                                                                                                          T. brucei <br /> doxycycline remained completely free parasites <br /> beyond 30 days remaining mouse                                                       Genetic validation crucial step identification <br /> group showed lethal parasitaemia day 23.                                                       drug target. However, importance demonstrat- <br /> Western blot analysis cells recovered infected                                              ing target &#226;&#8364;&#732;druggable&#226;&#8364;&#8482; cell be <br /> mouse confirmed parasites regained                                                        underestimated. As result high-throughput drug <br /> expression TRYS, suggesting tetracycline control                                                 screening medicinal chemistry campaign carried out <br /> had lost, common phenomenon conditional null                                                   Drug Discovery <span id='am-2' about='Thesaurus:Unit' typeof='owl:Thing'>Unit</span> Dundee, DDU 86439 (N-(3- <br />  <br />                                                                                                                                       &#194;&#169; 2009 The Authors <br />                                                                  Journal compilation &#194;&#169; 2009 Blackwell Publishing Ltd, Molecular Microbiology, 74, 529&#226;&#8364;&#8220;540 <br />                                                                                            Synthetase amidase activity TRYS essential 533 <br />  <br />                                                                        (14 mM) maintain 5% original <br />                    100                                                 T[SH]2 levels 72 h. As case cDKO cells <br />                                                                        (Fig. 2B), absence functional TRYS drug-treated <br />                                                                        cells led accumulation GSH, levels reaching <br />                     80                                                 fourfold higher seen untreated cells. The <br />                                                                        greater speed magnitude effects consis- <br />      Survival, % <br />  <br />  <br />  <br />  <br />                                                                        tent acute effects chemical inhibition compared <br />                     60 <br />                                                                        slower effects loss target activity genetic <br />                                                                        intervention (Fig. 2D). These observations suggest <br />                     40                                                 minimum concentration T[SH]2 compatible with <br />                                                                        survival ~3 mM [Table S3, assuming 108 cells = 5.8 ml <br />                                                                        (Opperdoes et al., 1984)]. <br />                     20 <br />  <br />                                                                        Is amidase activity TRYS essential to <br />                      0                                                 bloodstream T. brucei? <br />                          0   10             20             30 <br />                                                                        Following unequivocal chemical genetic valida- <br />                                   Time, days <br />                                                                        tion synthetase activity TRYS drug target in <br /> Fig. 3. Virulence cDKO parasites mice. Groups mice       bloodstream T. brucei, posed question: this <br /> were infected WT cDKO cells (1 &#194;&#165; 104 parasites).        bifunctional enzyme actually embody drug targets in <br /> Mice infected tetracycline-treated parasites dosed with <br />                                                                        one? Comparatively little known amidase <br /> doxycycline drinking water 3 days prior to, throughout, <br /> the infection. Data presented form Kaplan&#226;&#8364;&#8220;Meier        activity TRYS biological function remains <br /> survival plot. Symbols: WT, blue; cDKO presence              unclear. In previous kinetic structural studies, cys- <br /> doxycycline, red; cDKO absence doxycycline, green. <br />                                                                        teine position 59 equivalent Crithidia fasiculata <br />                                                                        (Oza et al., 2002a) L. major (Fyfe et al., 2008) <br /> (dimethylamino)propyl)-2-(3-(3-fluorophenyl)-1H-indazol-               enzymes demonstrated critical cata- <br /> 1-yl)acetamide, Fig. 4A) identified potent inhibi-            lytic mechanism TRYS-amidase. Replacement of <br /> tor recombinant T. brucei TRYS IC50 45 nM                cysteine 59 alanine Crithidia enzyme <br /> (full details published elsewhere). This com-                resulted functional synthetase devoid amidase <br /> pound inhibited growth WT cells HMI9-T media                 activity. To determine role TRYS-amidase para- <br /> with EC50 value 7.0 &#226;&#171;&#190; 0.2 mM following 72 h                    site viability virulence, knowledge exploited <br /> exposure. To confirm TRYS specifically targeted               generate TRYS conditional null mutant cell line <br /> by compound, TRYS SKO overexpressing (OE)                     (cDKO(C57A)) expressing amidase-&#226;&#8364;&#732;dead&#226;&#8364;&#8482; enzyme <br /> cell lines compared WT cells relative              tetracycline control (Fig. S3). <br /> sensitivity compound DDU 86439. Western analysis                       The amidase dead cell line viable HMI9-T <br /> and densitometry demonstrated TRYS protein levels                 medium presence tetracycline generation <br /> were approximately twofold lower SKO cells (Fig. 2B)                time 11.1 &#226;&#171;&#190; 0.1 h (Fig. 5A), marginally slower the <br /> and threefold higher OE cells compared WT                   original cDKO line (9.9 &#226;&#171;&#190; 0.02 h). Removal tetracycline <br /> levels (Fig. S2). Changes level TRYS                resulted slow death parasites 8 day <br /> cells correlated relative sensitivity com-          period viability lost day 6 culture, con- <br /> pound DDU 86439 EC50 values 1.2 &#226;&#171;&#190; 0.04                     firming TRYS synthetase, amidase activity is <br /> 23.0 &#226;&#171;&#190; 0.4 mM SKO OE cell lines respectively                   essential growth vitro. In identical manner the <br /> (Fig. 4B). cDKO cells, grown absence tetracy-                cDKO cell line, intracellular T[SH]2 levels fell following the <br /> cline 2 days prior analysis, hyper-            removal tetracycline cDKO(C57A) cultures while <br /> sensitive compound (EC50 0.46 &#226;&#171;&#190; 0.01 mM,                       GSH steadily accumulated (Fig. 5B). Parasites express- <br /> Fig. 4B), providing evidence TRYS spe-             ing amidase-dead TRYS markedly virulent <br /> cific target inhibitor.                                        mice expressing functional enzyme <br />    Intracellular thiol levels determined WT para-              (Fig. 5C). All mice infected cDKO(C57A) gradu- <br /> sites following incubation concentrations TRYS             ally succumbed infection 9 day period, day <br /> inhibitor corresponding 0.5, 1.0, 1.5 2.0 times             6&#226;&#8364;&#8220;15, cDKO-infected animals died day 5. The <br /> established EC50 value (7 mM) (Fig. 4C). Treatment                parasites recovered cDKO(C57A)-infected mice con- <br /> DDU 86439 resulted significant, dose-dependent                    tinued express mutated form TRYS enzyme, <br /> decrease levels intracellular T[SH]2. Trypano-               determined PCR sequence analysis genomic <br /> somes incubated highest levels compound               DNA (data shown). Four mice infected with <br />  <br /> &#194;&#169; 2009 The Authors <br /> Journal compilation &#194;&#169; 2009 Blackwell Publishing Ltd, Molecular Microbiology, 74, 529&#226;&#8364;&#8220;540 <br />  534 S. Wyllie et al. &#228;&#352;? <br />  <br />                                                              A <br />  <br />  <br />  <br />  <br />                B                                                            C <br />                                100                                                              400 <br />  <br />  <br />                                80 <br />                                                                                                 300 <br />  <br />  <br />  <br />  <br />                                                                             Thiols, % control <br />                Cell count, % <br />  <br />  <br />  <br />  <br />                                60 <br />  <br />                                                                                                 200 <br />                                40 <br />  <br />  <br />                                                                                                 100 <br />                                20 <br />  <br />  <br />  <br />                                 0                                                                 0 <br />                                      0.1   1         10          100                                  0   0.5           1         1.5   2 <br />                                            [Inhibitor], &#206;&#188;M                                                      Inhibitor, fold EC50 <br />  <br />  <br />                                                                                                       0   3.5           7        10.5   14 <br />                                                                                                                 [DDU 86439], &#206;&#188;M <br />  <br /> Fig. 4. Chemical targeting TRYS T. brucei. <br /> A. Chemical structure TRYS inhibitor DDU 86439 (N-(3-(dimethylamino)propyl)-2-(3-(3-fluorophenyl)-1H-indazol-1-yl)acetamide). <br /> B. EC50 values determined DDU 86439 WT (closed circles), SKO (open squares), TRYS-overexpressing (open circles) and <br /> cDKO cells grown absence tetracycline 2 days prior analysis (closed squares, dotted line). The curves non-linear fits of <br /> data using two-parameter EC50 equation provided GraFit (see Experimental procedures). EC50 values 7.1 &#226;&#171;&#190; 0.2, 1.2 &#226;&#171;&#190; 0.05, 23.3 &#226;&#171;&#190; 0.3 <br /> and 0.46 &#226;&#171;&#190; 0.01 mM determined WT, SKO, TRYS-overexpressing cDKO cell lines respectively. Data mean duplicate <br /> measurements. <br /> C. Analysis intracellular T[SH]2 (closed circles) GSH (open circles) levels T. brucei bloodstream parasites (WT) following incubation <br /> with compound DDU 86439 (72 h). Data represented percentage thiol levels untreated cells (0.51 0.42 nmol(108 cells)-1 <br /> for GSH T[SH]2 respectively; Table S1) measurement mean individual measurements. <br />  <br />  <br /> cDKO(C57A) cells absence doxycycline                               logical function remains. Several researchers have <br /> remained free parasites 20 days                      suggested ability hydrolyse T[SH]2 com- <br /> becoming terminally infected, mouse remained                       ponents, GSH spermidine enable cells to <br /> parasite-free entire 30 days experiment.                      respond conditions polyamine deprivation (Oza <br /> Western PCR analysis parasites recovered                         et al., 2002b; Fyfe et al., 2008). To examine hypoth- <br /> the infected animals revealed tetracycline control                  esis, cDKO cDKO(C57A) cell lines tested <br /> once lost mutated TRYS                          relative sensitivity difluoromethylornithine <br /> freely expressed (data shown). While evident                  (DFMO) (Fig. 6A), suicide inhibitor ornithine decar- <br /> TRYS-amidase activity essential vivo                 boxylase, rate-determining enzyme polyamine bio- <br /> vitro viability T. brucei, absence activity                   synthesis (Phillips Wang, 1987; Phillips et al., 1988). <br /> retards growth vitro decreases virulence                       Should primary role TRYS-amidase release <br /> mouse model.                                                                 polyamine stores T[SH]2 times need, would <br />                                                                              reasonable assume cells ability <br />                                                                              sensitive DFMO. However, cell <br /> What biological function TRYS-amidase in <br />                                                                              line expressing functional TRYS-amidase just <br /> T. brucei? <br />                                                                              sensitive DFMO cell line expressing the <br /> As TRYS-amidase required viability viru-                   &#226;&#8364;&#732;dead&#226;&#8364;&#8482; enzyme (EC50: 17.5 &#226;&#171;&#190; 0.5 16.6 &#226;&#171;&#190; 0.8 mM <br /> lence bloodstream T. brucei, question bio-                     respectively). <br />  <br />                                                                                                                         &#194;&#169; 2009 The Authors <br />                                                    Journal compilation &#194;&#169; 2009 Blackwell Publishing Ltd, Molecular Microbiology, 74, 529&#226;&#8364;&#8220;540 <br />                                                                                                                                                                         Synthetase amidase activity TRYS essential 535 <br />  <br />  A                                                                                               B                                                                         C <br />                                                                                                                      180 <br />                                  1e10 <br />                                                                                                                      160                                                                 100 <br />                                   1e9 <br /> Cumulative cell numbers, ml-1 <br />  <br />  <br />  <br />  <br />                                                                                                                      140 <br />                                   1e8                                                                                                                                                     80 <br />                                                                                                                      120 <br />  <br />  <br />  <br />  <br />                                                                                                  Thiols, % control <br />  <br />  <br />  <br />  <br />                                                                                                                                                                            Survival, % <br />                                   1e7 <br />                                                                                                                      100 <br />                                                                                                                                                                                           60 <br />                                   1e6                                                                                 80 <br />  <br />                                   1e5                                                                                 60                                                                  40 <br />  <br />                                 10000                                                                                 40 <br />                                                                                                                                                                                           20 <br />                                  1000                                                                                 20 <br />  <br />                                                                                                                        0 <br />                                   100 <br />                                                                                                                                                                                              0 <br />                                         0                   2          4          6     8                                  0       2                           4                                 0           10            20   30 <br />                                                                      Time, days                                                  Time, days                                                                       Time, days <br />  <br /> Fig. 5. In vitro vivo characterization TRYS-amidase &#226;&#8364;&#732;dead&#226;&#8364;&#8482; cell line. <br /> A. The growth cDKO(C57A) cell line HMI9-T medium monitored presence (closed circles) absence tetracycline <br /> (open circles, dashed line).The arrow indicates point viable cells longer recoverable subcultured 10 days <br /> in medium containing tetracycline. <br /> B. Intracellular T[SH]2 (closed circles) GSH (open circles) levels cDKO(C57A) cells following removal tetracycline cultures. <br /> Each data point represents means &#226;&#171;&#190; standard deviations triplicate determinations. <br /> C. Groups mice infected WT cDKO(C57A) cells (1 &#194;&#165; 104 parasites). Mice infected tetracycline-treated parasites <br /> were dosed doxycycline drinking water 3 days prior to, throughout, infection. Data presented form a <br /> Kaplan&#226;&#8364;&#8220;Meier survival plot. Symbols: WT, blue; cDKO presence doxycycline, red; cDKO absence doxycycline, green. <br />  <br />  <br />   To determine reduced virulence                                                                                    shown dosing mice manner increased <br /> cDKO(C57A) cell line attributed inability                                                                            parasite polyamine levels extent DFMO <br /> access T[SH]2-conjugated polyamines, groups                                                                                         longer cure infection (McCann et al., 1981; <br /> cDKO(C57A)-infected mice given daily bolus                                                                                   Nathan et al., 1981). Similarly, hypothesized that <br /> spermidine intraperitoneal injection. Previous studies                                                                             increased polyamine levels cDKO(C57A) cells may <br />  <br />  <br />                                             A                                                                                          B <br />                                                             100                                                                                      100 <br />  <br />  <br />  <br />                                                                 80                                                                                   80 <br />                                             Cell count, % <br />  <br />  <br />  <br />  <br />                                                                                                                                        Survival, % <br />  <br />  <br />  <br />  <br />                                                                 60                                                                                   60 <br />  <br />  <br />  <br />                                                                 40                                                                                   40 <br />  <br />  <br />  <br />                                                                 20                                                                                   20 <br />  <br />  <br />  <br />                                                                 0                                                                                     0 <br />                                                                            1                10                             100                             0   1   2   3                 4       5   6   7        8   9   10 <br />                                                                                       [DFMO], &#206;&#188;M                                                                                         Time, days <br />  <br /> Fig. 6. The effect polyamines growth virulence cDKO(C57A) parasites. <br /> A. EC50 values determined DFMO cDKO (closed circles) cDKO(C57A) cells (closed circles). The curves the <br /> non-linear fits data using two-parameter EC50 equation provided GraFit (see Experimental procedures). EC50 values 17.5 &#226;&#171;&#190; 0.5 and <br /> 16.6 &#226;&#171;&#190; 0.8 mM determined cDKO cDKO(C57A) cell lines respectively. Data mean duplicate measurements. <br /> B. Groups mice infected cDKO cDKO(C57A) cells (1 &#194;&#165; 104 parasites). All mice infected tetracycline-treated <br /> parasites dosed doxycycline drinking water. One set cDKO cDKO(C57A)-infected mice received daily <br /> intraperitoneal injections spermidine (100 mg kg-1). Data presented form Kaplan&#226;&#8364;&#8220;Meier survival plot. Symbols: cDKO, blue; <br /> cDKO plus spermidine, red; cDKO(C57A), green; cDKO(C57A) plus spermidine, yellow. <br />  <br /> &#194;&#169; 2009 The Authors <br /> Journal compilation &#194;&#169; 2009 Blackwell Publishing Ltd, Molecular Microbiology, 74, 529&#226;&#8364;&#8220;540 <br />  536 S. Wyllie et al. &#228;&#352;? <br />  <br /> result return levels virulence seen cDKO          high metabolic turnover. Given many <br /> infections. Mice inoculated cDKO cell line suc-            existing drugs interact directly indirectly T[SH]2 <br /> cumbed infection days 4 5, regardless              metabolism (Fairlamb, 2003), inhibitors TRYS could <br /> presence absence additional spermidine (Fig. 6B).             prove ideal candidates combination therapy. RNAi <br /> Once again, cDKO(C57A) parasites virulent             studies revealed TRYS-depleted T. brucei pro- <br /> than expressing functional TRYS-amidase,               cyclics significantly susceptible trypanocides, <br /> mice heavily infected days 6 10.               melarsoprol triostam, known act on <br /> Most significantly, daily dosing infected mice sper-        T[SH]2 metabolism (Ariyanayagam et al., 2005). In addi- <br /> midine absolutely effect virulence             tion, procyclics sensitive the <br /> cDKO(C57A) cells. The failure additional spermidine           redox-cycling drug nifurtimox, currently phase III clinical <br /> enhance virulence cells suggest             trials use African sleeping sickness. Collec- <br /> the primary function TRYS-amidase enable               tively, findings suggest use drugs target- <br /> access T[SH]2-conjugated polyamines.                             ing TRYS, combination existing drugs, prove <br />    These findings bring question hypothesis           effective strategy treating T. brucei infections. <br /> TRYS-amidase plays pivotal role regulation of <br /> cellular polyamines (Shim Fairlamb, 1988; Tetaud <br /> et al., 1998; Oza et al., 2002b; Fyfe et al., 2008). If is <br />                                                                     Experimental procedures <br /> not case, biological function           Cell lines culture conditions <br /> amidase T. brucei? Kinetic analysis recombinant <br />                                                                     Trypanosoma brucei bloodstream-form &#226;&#8364;&#732;single marker&#226;&#8364;&#8482; S427 <br /> T. brucei T. cruzi TRYS shown amidase <br />                                                                     (T7RPOL TETR NEO) knockouts cultured 37&#194;&#176;C <br /> activity enzymes equivalent 1% of <br />                                                                     modified HMI9 medium (56 mM 1-thioglycerol substi- <br /> the synthetase activity optimal assay conditions              tuted 200 mM 2-mercaptoethanol) supplemented with <br /> (Oza et al., 2002b; 2003). Should true          2.5 mg ml-1 G418 maintain expression T7 RNA poly- <br /> in vivo enzyme, difficult amidase        merase tetracycline repressor protein (Hirumi and <br /> have meaningful impact intracellular polyamine               Hirumi, 1989). Cultures initiated 1 &#194;&#165; 105 cells ml-1 <br /> levels. Alternatively, low enzymatic activity recom-         subcultured cell densities approached <br /> binant TRYS-amidase readily explained T[SH]2            1&#226;&#8364;&#8220;2 (&#194;&#165; 106) ml-1. Single marker (WT), SKO, cDKO OE <br />                                                                     cell lines grown continuously presence the <br /> and GspdSH natural substrates this <br />                                                                     appropriate drug selection (see details). <br /> enzyme. In Gram-positive bacteria Mycobacterium                    In order examine effects inhibitors growth of <br /> smegmatis, thiol S-conjugate amidase char-               parasites, triplicate cultures containing inhibitor <br /> acterized specifically hydrolyses thiol-conjugated            seeded 1 &#194;&#165; 105 trypanosomes ml-1. Cell densities <br /> xenobiotics, resulting detoxification xenobiotic          determined using CASY Model TT cell counter <br /> and recycling thiol (Newton et al., 2000). It tempt-      (Sch&#195;&#164;rfe) culture 72 h. EC50 values determined <br /> ing suggest TRYS-amidase play similar role            using following two-parameter equation non-linear <br />                                                                     regression using GraFit: <br /> in T. brucei enzyme highly selective for <br /> S-conjugates T[SH]2 formed trypanothione                                                       100 <br />                                                                                            y= <br />                                                                                                       [I] &#226;&#381;&#382; <br />                                                                                                             m <br /> S-transferase (Vickers Fairlamb, 2004). Studies are <br />                                                                                                 1+ &#226;&#381;&#8250; <br /> underway test validity hypothesis. What                                          &#226;&#381;? EC50 &#226;&#381;&#160; <br /> irrefutable study TRYS-amidase           experimental data corrected background <br /> viable drug target African trypanosome.                      cell density expressed percentage uninhibited <br />                                                                     control cell density. In equation [I] represents inhibitor <br />                                                                     concentration m slope factor. <br /> Implications parasite chemotherapy <br />  <br /> In study, TRYS chemically genetically <br />                                                                     Generation knockout, overexpression recovery <br /> validated drug target bloodstream T. brucei. We <br />                                                                     constructs <br /> have shown TRYS null trypanosomes unable to <br /> establish infection mice chemical targeting          The primers used summarized Table 1 were <br /> of enzyme leads parasite death. The potency          designed using T. brucei trypanothione synthetase <br /> lead TRYS inhibitor bloodstream trypanosomes                (TRYS) sequence GeneDB (Tb927.2.4370) template. <br />                                                                     The accuracy assembled constructs verified by <br /> (EC50 7 mM) compares favourably eflornithine <br />                                                                     sequencing. TRYS gene replacement cassettes gener- <br /> (EC50 17.5 mM, Fig. 6A), current front-line drug used in <br />                                                                     ated amplifying region DNA encompassing the <br /> the treatment HAT. Like eflornithine, DDU 86439           5&#226;&#8364;&#178;-UTR, open reading frame (ORF) 3&#226;&#8364;&#178;-UTR T. brucei <br /> rapidly cidal decrease intracellular T[SH]2              TRYS genomic DNA primers 5&#226;&#8364;&#178;UTR-NotI_s and <br /> content compatible dilution cell division            3&#226;&#8364;&#178;UTR-NotI_as, using Pfu polymerase. This sequence was <br />  <br />                                                                                                                 &#194;&#169; 2009 The Authors <br />                                            Journal compilation &#194;&#169; 2009 Blackwell Publishing Ltd, Molecular Microbiology, 74, 529&#226;&#8364;&#8220;540 <br />                                                                                                 Synthetase amidase activity TRYS essential 537 <br />  <br /> Table 1. Upper case letters refer nucleotides corresponding gene sequences T. brucei; lower case refers additional sequences used <br /> in generating constructs. <br />  <br /> Primer                                     Primer sequence <br />  <br /> 5&#226;&#8364;&#178;UTR-NotI_s                                    5&#226;&#8364;&#178;-ataagaatgcggccgcTGTGGTTGTTGTTTC-3&#226;&#8364;&#178; <br /> 5&#226;&#8364;&#178;UTR-HindIII/PmeI_as                           5&#226;&#8364;&#178;-gtttaaacttacggaccgtcaagcttTTGTTTCAATTGCTTTTCC-3&#226;&#8364;&#178; <br /> 3&#226;&#8364;&#178;UTR-PmeI/BamHI_s                              5&#226;&#8364;&#178;-gacggtccgtaagtttaaacggatccCACAACCCTTCCGTTTTG-3&#226;&#8364;&#178; <br /> 3&#226;&#8364;&#178;UTR-NotI_as                                   5&#226;&#8364;&#178;-ataagtaagcggccgcGGAATAAACATAAAGC-3&#226;&#8364;&#178; <br /> TbTRYS-HindIII_s                                5&#226;&#8364;&#178;-cggaaggagaaagcttatgggcagcagccat-3&#226;&#8364;&#178; <br /> TbTRYS-BamHI_as                                 5&#226;&#8364;&#178;-ggatccCTACATTTGAATACGTACGGGACCAAACGGAGATTCGAGCCCAGTGATGAGCTT-3&#226;&#8364;&#178; <br /> TbTRYS(C57A) mut_s                              5&#226;&#8364;&#178;-cttttctgcggtttcaaataccaagctgtagaattt-3&#226;&#8364;&#178; <br /> TbTRYS(C57A) mut_as                             5&#226;&#8364;&#178;-aaattctacagcttggtatttgaaaccgcagaaaag-3&#226;&#8364;&#178; <br />  <br /> Restriction endonuclease sites underlined mutations used generate amidase-dead TRYS indicated bold. <br />  <br />  <br />  <br />  <br /> then used template amplification individual          pLew100_TbTRYS mutated version vector <br /> regions used assembly replacement cassettes con-               pLew100_TbTRYS(C57A) cultured presence of <br /> taining selectable drug-resistance genes puromycin                   2.5 mg ml-1 blasticidin addition puromycin. Prior to <br /> N-acetyl transferase (PAC) hygromycin phosphotrans-                  removal remaining TRYS allele, expression the <br /> ferase (HYG), exactly previously described (Martin                recombinant TRYS proteins induced addition of <br /> Smith, 2005).                                                            tetracycline (2 mg ml-1, 72 h) culture medium. A cDKO <br />    To generate recovery construct pLew100_TbTRYS,                cell line finally generated following replacement the <br /> TRYS ORF T. brucei amplified genomic DNA                   final TRYS allele HYG. The resulting cell line was <br /> using TbTRYS-HindIII sense TbTRYS-BamHI antisense                    cultured presence hygromycin (4.0 mg ml-1) in <br /> primers, cloned pCR-Blunt II TOPO (Invitrogen). The             addition previously described drugs. The TRYS <br /> pCR-Blunt II-TOPO-TbTRYS construct digested                     overexpression cell line generated directly trans- <br /> with HindIII BamHI resulting fragment ligated           forming single marker bloodstream parasites the <br /> the HindIII/BamHI cloning site modified pLew100                     pLew100_TbTRYS vector inducing recombinant protein <br /> tetracycline-inducible expression vector (Wirtz et al., 1999)            expression addition tetracycline. At step the <br /> which contains blasticidin S transferase (BSD) select-            generation transgenic cell lines, parasites were <br /> able gene marker (kindly supplied Dr Kirstee Martin). The             cloned serial dilution. <br /> resulting rescue vector used TRYS overex- <br /> pression vector single marker T. brucei bloodstream <br /> parasites.                                                               Southern blot analyses transgenic T. brucei cell lines <br />    An additional recovery construct generated containing <br /> a mutated version T. brucei TRYS gene. Site-directed              The ORF T. brucei TRYS amplified PCR (using the <br /> mutagenesis carried following QuikChange&#194;&#174; pro-               primers previously described cloning TbTRYS into <br /> tocol (Stratagene) using KOD HotStart DNA poly-                  pLew100-BSD) PCR DIG Probe Synthesis Kit <br /> merase (Novagen). Using pLew100_TbTRYS construct                     (Roche). The resulting digoxigenin-labelled TbTRYS product <br /> as template, C A <span id='am-239' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-240' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-241' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-242' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-243' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-244' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-245' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-246' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-247' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-248' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-249' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-250' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-251' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-252' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-253' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-254' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-255' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-256' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-257' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-258' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-259' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-260' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-261' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-262' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-263' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-264' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-265' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-266' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-267' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-268' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-269' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-270' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-271' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-272' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-273' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-274' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-275' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-276' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-277' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-278' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-279' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-280' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-281' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-282' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-283' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-284' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-285' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-286' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-287' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-288' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-289' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-290' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-291' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-292' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-293' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-294' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-295' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-296' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-297' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-298' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-299' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-300' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-301' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-302' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-303' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-304' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-305' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-306' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-307' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-308' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-309' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-310' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-311' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-312' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-313' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-314' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-315' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-316' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span>mutation</span> introduced position 57           used probe. Samples genomic DNA (5 mg) from <br /> of T. brucei TRYS generated PCR resulting                  single marker transgenic cell lines digested the <br /> modified construct &#226;&#8364;&#8220; pLew100_TbTRYS(C57A).                               restriction endonuclease PstI, digestion products were <br />                                                                          separated 0.8% agarose gel transferred to <br />                                                                          positively charged nylon membrane (Roche). The mem- <br /> Generation transgenic T. brucei cell lines                            brane hybridized overnight DIG Easy Hyb solution <br />                                                                          (Roche) 42&#194;&#176;C DIG-labelled TRYS ORF probe (2 ml <br /> Knockout, recovery overexpression constructs pre-               PCR product). Following hybridization, membranes were <br /> pared using QIAprep Miniprep Plasmid Kit (Qiagen). DNA                   washed twice low stringency conditions (25&#194;&#176;C, 2 &#194;&#165; 5 min, <br /> was digested NotI, ethanol precipitated redissolved             2&#194;&#165; SSC 0.1% SDS) twice high stringency condi- <br /> in sterile water final concentration 1 mg ml-1. Trypano-         tions (68&#194;&#176;C, 2 &#194;&#165; 15 min, 0.5&#194;&#165; SSC 0.1% SDS), 1&#194;&#165; <br /> somes electroporated 5 mg DNA using reagents                SSC comprises 150 mM sodium chloride 50 mM sodium <br /> from Human T cell Nucleofector kit manufacturers&#226;&#8364;&#8482;             acetate, pH 7.0. Bound probe detected using DIG <br /> instructions using programme X-001 Nucleofector               immunological detection kit (Roche) manufacturers&#226;&#8364;&#8482; <br /> II electroporator (Amaxa, Cologne, Germany) (Burkard et al.,             instructions. <br /> 2007). <br />    The cDKO TRYS generated sequentially replac- <br /> ing endogenous TRYS genes drug-resistance genes.                Western blot analysis T. brucei cell lysates <br /> The TRYS allele replaced drug-resistance <br /> gene PAC resulting SKO cell line cultured              Polyclonal antisera T. brucei TRYS raised in <br /> the continuous presence 0.1 mg ml-1 puromycin. The SKO                adult male Wistar rats. An initial injection 100 mg purified <br /> cells transformed recovery vector              antigen, emulsified complete Freund&#226;&#8364;&#8482;s adjuvant, fol- <br />  <br /> &#194;&#169; 2009 The Authors <br /> Journal compilation &#194;&#169; 2009 Blackwell Publishing Ltd, Molecular Microbiology, 74, 529&#226;&#8364;&#8220;540 <br />  538 S. Wyllie et al. &#228;&#352;? <br />  <br /> lowed identical booster injections antigen emulsified     In vivo studies <br /> in Freund&#226;&#8364;&#8482;s incomplete adjuvant 2 week intervals. <br />    Trypanosoma brucei cell extracts (1 &#194;&#165; 107 parasites        Wild-type transgenic bloodstream T. brucei parasites <br /> per lane) separated SDS/PAGE subsequently               cultured absence selectable drugs (hygromy- <br /> transferred nitrocellulose. After blocking 7%             cin, blasticidin, puromycin G418) 24 h prior infec- <br /> skimmed milk phosphate buffered saline (PBS) 1 h,            tion mice. During time, cDKO cells grown the <br /> blots incubated T. brucei TRYS (1:700 dilu-        presence absence 1 mg ml-1 tetracycline. These para- <br /> tion) T. brucei PTR1 (1:500) (Sienkiewicz et al., 2008)          sites used infect groups mice (dosed with <br /> polyclonal antiserum 1 h, washed PBS containing 0.1%         doxycycline respectively) single intraperito- <br /> (v/v) Tween-20, incubated secondary anti-           neal injection 104 parasites 0.2 ml HMI9-T medium. <br /> body [rabbit anti(rat IgG)] (Dako, Ely, UK; 1:10 000 dilution).     The plus doxycycline group animals dosed doxy- <br /> Immunoblots developed using ECL plus (enhanced             cycline drinking water (0.2 mg ml-1 5% sucrose <br /> chemiluminescence) GE Healthcare (Piscat-               solution) 5 days prior infection freshly prepared <br /> away, NJ, USA).                                                     second day duration experiment. Animals <br />                                                                     inspected daily clinical signs infection wet <br />                                                                     smears tail blood examined microscopically. Parasi- <br /> Drug discovery                                                      taemia determined using Neubauer haemocytometer, <br />                                                                     previously described (Sienkiewicz et al., 2008). Mice that <br /> A high-throughput screening campaign 63 000 compounds            exceeded parasitaemia &gt; 108 ml-1 humanely killed, <br /> led identification novel chemical classes      prior experience indicated animals would <br /> T. brucei TRYS inhibitor. Chemical development               succumb overwhelming infection following day. <br /> of lead compounds led identification com- <br /> pound DDU 86439 (N-(3-(dimethylamino)propyl)-2-(3-(3- <br /> fluorophenyl)-1H-indazol-1-yl)acetamide) (patent pending)           Acknowledgements <br /> which inhibited recombinant TRYS potency of <br /> 0.045 mM inhibited growth bloodstream trypano-           Our appreciation goes Adel Ibrahim University <br /> somes EC50 6.9 &#226;&#171;&#190; 0.2 mM. DDU 86439 pre-              Dundee Cloning Service help site-directed <br /> pared synthetic steps indazole. Briefly, indazole      mutagenesis cloning pLew100 Dr Natasha Sien- <br /> was iodinated position, previously described        kiewicz helpful advice concerning generation trans- <br /> (Edwards et al., 2003). The resultant aryl iodide served            genic organisms. We thank Dr Paul Wyatt, Director of <br /> as substrate Suzuki coupling reaction                Dundee Drug Discovery <span id='am-551' about='Thesaurus:Unit' typeof='owl:Thing'>Unit</span> invaluable advice the <br /> 3-fluorophenylboronic acid analogous manner           medicinal chemistry presented paper. This work was <br /> previously described (El Kazzouli et al., 2005). The indazole       funded grants Wellcome Trust (WT 079838; WT <br /> was N 1-alkylated treatment sodium hydride         077705; WT 083481). <br /> ethyl bromoacetate. The resulting crude ester hydro- <br /> lysed treatment sodium hydroxide water/ <br /> tetrahydrofuran. Following acidic workup, product               References <br /> carboxylic acid purified silica column chromatography. <br /> The amide synthesis accomplished standard carbo-            Alibu, V.P., Richter, C., Voncken, F., Marti, G., Shahi, S., <br /> diimide chemistry utilizing N-(3-Dimethylaminopropyl)-                 Renggli, C.K., et al. (2006) The role Trypanosoma brucei <br /> N&#226;&#8364;&#178;-ethylcarbodiimide,        1-Hydroxybenzotriazole,      N,N-         MRPA melarsoprol susceptibility. Mol Biochem Parasitol <br /> Diisopropylethylamine 3-(dimethylamino)-1-propylamine              146: 38&#226;&#8364;&#8220;44. <br /> to furnish title compound, purified silica         Ariyanayagam, M.R., Fairlamb, A.H. (2001) Ovothiol and <br /> column chromatography. Full details chemical synthesis           trypanothione antioxidants trypanosomatids. Mol <br /> this inhibitors published elsewhere.               Biochem Parasitol 115: 189&#226;&#8364;&#8220;198. <br />                                                                     Ariyanayagam, M.R., Oza, S.L., Guther, M.L., Fairlamb, <br />                                                                        A.H. (2005) Phenotypic analysis trypanothione syn- <br /> Analysis intracellular thiols                                       thetase knockdown African trypanosome. Biochem J <br />                                                                        391: 425&#226;&#8364;&#8220;432. <br /> To determine effect inhibitor DDU 86439 intracellu-       Bacchi, C.J., Yarlett, N. (1995) Polyamine metabolism. In <br /> lar thiol levels, cultures containing 1 &#194;&#165; 105 bloodstream trypa-       Biochemistry Molecular Biology Parasites. Marr, <br /> nosomes ml-1 incubated varying concentrations             J.J., M&#195;&#188;ller, M. (eds). London: Academic Press, pp. <br /> inhibitor DDU 86439 equivalent 0.5, 1.0, 1.5 2&#194;&#165;             119&#226;&#8364;&#8220;131. <br /> previously determined EC50 (6.9 &#226;&#171;&#190; 0.2 mM). Following incuba-        Barrett, M.P., Fairlamb, A.H. (1999) The biochemical <br /> tion 72 h, cells (1 &#194;&#165; 108) collected centrifugation        basis arsenical-diamidine cross-resistance African <br /> (900 g, 10 min, 4&#194;&#176;C), washed ice-cold PSG buffer               trypanosomes. Parasitol Today 15: 136&#226;&#8364;&#8220;140. <br /> (PBS, pH 8.0, 1.5% (w/v) glucose 0.5 mg ml-1 BSA)           Bateman, A., Rawlings, N.D. (2003) The CHAP domain: a <br /> derivatised monobromobimane, described previously              large family amidases including GSP amidase pep- <br /> (Shim Fairlamb, 1988). Acid-soluble thiols sepa-              tidoglycan hydrolases. Trends Biochem Sci 28: 234&#226;&#8364;&#8220;237. <br /> rated ion-paired, reverse phase HPLC ion-paired            Burkard, G., Fragoso, C.M., Roditi, I. (2007) Highly effi- <br /> Ultrasphere C18 column using Dionex Ultimate 3000 instru-            cient stable transformation bloodstream forms Trypa- <br /> ment fitted Dionex RF-2000 fluorometer.                         nosoma brucei. Mol Biochem Parasitol 153: 220&#226;&#8364;&#8220;223. <br />  <br />                                                                                                                 &#194;&#169; 2009 The Authors <br />                                            Journal compilation &#194;&#169; 2009 Blackwell Publishing Ltd, Molecular Microbiology, 74, 529&#226;&#8364;&#8220;540 <br />                                                                                         Synthetase amidase activity TRYS essential 539 <br />  <br /> Chang, T., Milne, K.G., Guther, M.L.S., Smith, T.K.,              Nathan, H.C., Amole, B.O., et al. (1981) Further studies on <br />   Ferguson, M.A.J. (2002) Cloning Trypanosoma brucei               difluoromethylornithine African trypanosomes. Med Biol <br />   Leishmania major genes encoding GlcNAc-                     59: 434&#226;&#8364;&#8220;440. <br />   phosphatidylinositol de-n-acetylase glycosylphosphati-         Martin, K., Smith, T.K. (2005) The myo-inositol-1- <br />   dylinositol biosynthesis essential african           phosphate synthase gene essential Trypanosoma <br />   sleeping sickness parasite. J Biol Chem 277: 50176&#226;&#8364;&#8220;                 brucei. Biochem Soc Trans 33: 983&#226;&#8364;&#8220;985. <br />   50182.                                                            Mukhopadhyay, R., Dey, S., Xu, N., Gage, D., Lightbody, J., <br /> Comini, M.A., Guerrero, S.A., Haile, S., Menge, U., Lunsdorf,         Ouellette, M., Rosen, B.P. (1996) Trypanothione over- <br />   H., Floh&#195;&#169;, L. (2004) Validation Trypanosoma brucei           production resistance antimonials arsenicals in <br />   trypanothione synthetase drug target. Free Radic Biol            Leishmania. Proc Natl Acad Sci USA 93: 10383&#226;&#8364;&#8220;10387. <br />   Med 36: 1289&#226;&#8364;&#8220;1302.                                                Nathan, H.C., Bacchi, C.J., Hutner, S.H., Rescigno, D., and <br /> Croft, S.L., Sundar, S., Fairlamb, A.H. (2006) Drug               Sjoerdsma, A. (1981) Antagonism polyamines the <br />   Resistance Leishmaniasis. Clin Microbiol Rev 19: 111&#226;&#8364;&#8220;            curative effects a-difluoromethylornithine Trypano- <br />   126.                                                                soma brucei brucei infections. Biochem Pharmacol 30: <br /> Dormeyer, M., Reckenfelderbaumer, N., Ludemann, H.,               3010&#226;&#8364;&#8220;3013. <br />   Krauth-Siegel, R.L. (2001) Trypanothione-dependent syn-           Newton, G.L., Av-Gay, Y., Fahey, R.C. (2000) A novel <br />   thesis deoxyribonucleotides Trypanosoma brucei                mycothiol-dependent detoxification pathway mycobacte- <br />   ribonucleotide reductase. J Biol Chem 276: 10602&#226;&#8364;&#8220;10606.             ria involving mycothiol S-conjugate amidase. Biochemistry <br /> Edwards, M.L., Cox, P.J., Amendola, S., Deprets, S.D.,                39: 10739&#226;&#8364;&#8220;10746. <br />   Gillespy, T.A., Edlin, C.D., et al. (2003) Benzimidazoles         Opperdoes, F.R., Baudhuin, P., Coppens, I., Roe, C., <br />   analogues use protein kinases inhibitors.          Edwards, S.W., Weijers, P.J., Misset, O. (1984) Puri- <br />   Aventis Pharmaceuticals Inc. Patent WO/2003/035065.                 fication, morphometric analysis, characterization the <br /> El Kazzouli, S., Bouissane, L., Khoulli, M., Guillaumet, G.       glycosomes (microbodies) protozoan hemoflagellate <br />   (2005) Synthesis 4-substituted 3,4-disubstituted             Trypanosoma brucei. J Cell Biol 98: 1178&#226;&#8364;&#8220;1184. <br />   indazole derivatives palladium-mediated cross-coupling         Oza, S.L., Ariyanayagam, M.R., Fairlamb, A.H. (2002a) <br />   reactions. Tetrahedron Lett 46: 6163&#226;&#8364;&#8220;6167.                          Characterization recombinant glutathionylsper <br /> </body></html>